Page last updated: 2024-08-26

fulvestrant and Prostatitis

fulvestrant has been researched along with Prostatitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernoulli, J; Lammintausta, R; Santti, R; Yatkin, E1
Bernoulli, J; Santti, R; Streng, T; Talvitie, EM; Yatkin, E1

Other Studies

2 other study(ies) available for fulvestrant and Prostatitis

ArticleYear
Fispemifene [Z-2-{2-[4-(4-chloro-1,2-diphenylbut-1-enyl)-phenoxy]ethoxy}-ethanol], a novel selective estrogen receptor modulator, attenuates glandular inflammation in an animal model of chronic nonbacterial prostatitis.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 327, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Estradiol; Estrogen Antagonists; Fos-Related Antigen-2; Fulvestrant; Immunohistochemistry; Male; Organ Size; Prolactin; Prostatitis; Rats; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Testosterone

2008
Urodynamic changes in a noble rat model for nonbacterial prostatic inflammation.
    The Prostate, 2007, Jun-01, Volume: 67, Issue:8

    Topics: Animals; Electromyography; Estradiol; Estrogen Antagonists; Fulvestrant; Histocytochemistry; Male; Organ Size; Prostatitis; Rats; Statistics, Nonparametric; Testosterone; Urinary Bladder; Urination Disorders

2007